HCA Healthcare Inc (HCA) Q1 2026 (USD) EPS 7.15 (exp. 7.14), Revenue 19.1bln (exp. 19.08bln). Reaffirms 2026 guidance.
- Dividend of 0.78/shr.
Context
HCA Healthcare's Q1 2026 results slightly exceeded expectations on both EPS and revenue, indicating strong operational performance. The reaffirmation of 2026 guidance suggests confidence in ongoing growth, which may positively influence investor sentiment and support equity pricing in the healthcare sector. Additionally, the announced dividend reflects a commitment to returning value to shareholders, potentially enhancing attractiveness for income-focused investors.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#HCA HOLDINGS INC#HCA.US#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#HEALTH CARE FACILITIES#METALS & MINING#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#HCA HEALTHCARE INC#HCA#DXY#US EQUITIES